Cargando…
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy
SIMPLE SUMMARY: Solid tumors are highly immunosuppressive and develop multiple inhibitory mechanisms that must be targeted simultaneously for successful cancer immunotherapy. Adenoviral vectors are promising cancer gene therapy vectors due to their inherent ability to stimulate multiple immune pathw...
Autores principales: | Rosewell Shaw, Amanda, Porter, Caroline, Biegert, Greyson, Jatta, Lisa, Suzuki, Masataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179443/ https://www.ncbi.nlm.nih.gov/pubmed/35681750 http://dx.doi.org/10.3390/cancers14112769 |
Ejemplares similares
-
Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies
por: Wang, Daniel, et al.
Publicado: (2023) -
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives
por: McKenna, Mary K., et al.
Publicado: (2020) -
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
por: Farzad, Lisa, et al.
Publicado: (2014) -
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
por: Farzad, Lisa M., et al.
Publicado: (2014) -
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
por: Rosewell Shaw, Amanda, et al.
Publicado: (2018)